UNIVERSITY OF MIAMI
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
Timing of PDA Closure and Respiratory Outcome in Premature Infants
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2014-02-05
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 105
- Registration Number
- NCT00802685
- Locations
- 🇺🇸
Jackson Memorial Hospital/Holtz Children's Center, Miami, Florida, United States
Coagulation Changes in Trauma Patients
Completed
- Conditions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 40
- Registration Number
- NCT00795743
- Locations
- 🇺🇸
Ryder Trauma Center, Miami, Florida, United States
Vasopressin Versus Catecholamines for Cerebral Perfusion Pressure Control in Brain Injured Trauma Patients
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2014-12-12
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 96
- Registration Number
- NCT00795366
- Locations
- 🇺🇸
Ryder Trauma Center, Miami, Florida, United States
Heart Rate Variability in Trauma Patients
Completed
- Conditions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2015-02-09
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 95
- Registration Number
- NCT00795535
- Locations
- 🇺🇸
Ryder Trauma Center, Miami, Florida, United States
Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
- First Posted Date
- 2008-10-16
- Last Posted Date
- 2014-04-16
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 21
- Registration Number
- NCT00773136
- Locations
- 🇺🇸
University of Miami, Bascom Palmer Eye Institute, Miami, Florida, United States
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2017-12-11
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 3
- Registration Number
- NCT00772668
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
Ranibizumab for the Inhibition of Neovascularization in Pterygia
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 10
- Registration Number
- NCT00768963
- Locations
- 🇺🇸
Bascom Palmer Eye Institute, Miami, Florida, United States
Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 5
- Registration Number
- NCT00769145
- Locations
- 🇺🇸
Bascom Palmer Eye Institute, Miami, Florida, United States
The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 65
- Registration Number
- NCT00768066
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 30
- Registration Number
- NCT00754247
- Locations
- 🇺🇸
University of Miami Skin Research Group Office, Miami, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath